The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 62 , ISSUE 2 ( April-June, 2020 ) > List of Articles


Isoniazid-induced Alopecia: A Rare Entity

Keywords : Alopecia, Isoniazid, Dermatology

Citation Information : Isoniazid-induced Alopecia: A Rare Entity. Indian J Chest Dis Allied Sci 2020; 62 (2):69-70.

DOI: 10.5005/ijcdas-62-2-69

License: CC BY-NC 4.0

Published Online: 07-11-2022

Copyright Statement:  Copyright © 2020; The Author(s).


A 32-year-old male patient diagnosed with smear positive pulmonary tuberculosis presented with excessive hair fall two months after starting anti-tuberculosis treatment. In the absence of any specific metabolic or dermatological cause, drug-induced alopecia was suspected. A review of the literature revealed isoniazid as the culprit drug. Isoniazid was withdrawn and the patient started having new hair growth gradually.

PDF Share
  1. World Health Organization. Global Tuberculosis Report 2018. Geneva: World Health Organization; 2018.
  2. Gilman AG, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. 8th edition. Oxford: Pergamon Press; 1990:p.1146–64.
  3. Adler SN, Gasbarra DB. A Pocket Manual of Differential Diagnosis. 4th edition. Lippincott Williams and Wilkins; 2005.
  4. Tosi A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth: incidence, management and avoidance. Drug Saf 1994;10:310–7.
  5. FitzGerald JM, Tuner MT, Dean S, Elwood RK. Alopecia side effect of antituberculosis drugs. Lancet 1996;347:472.
  6. Sharma PK, Gautam RK, Bhardwaj M, Kar HK. Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption. J Dermatol 2001;28:737–41.
  7. Gupta KB, Kumar V, Vishvkarma S, Shandily R. Isoniazidinduced alopecia. Lung India 2011;28:60–1.
  8. Arshad N, Jain RC, Verma K. Ethionamide induced alopecia. Indian J Tub 1984;31:173–4.
  9. Gupta DK, Kumar R, Kumar V, Aggarwal AK. Diffuse toxic alopecia due to thiacetazone. Indian J Chest Dis Allied Sci 1993;25:74–5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.